These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8741126)
1. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acarín N; Río J; Fernández AL; Tintoré M; Durán I; Galán I; Montalban X Acta Neurol Scand; 1996; 93(2-3):99-103. PubMed ID: 8741126 [TBL] [Abstract][Full Text] [Related]
2. CSF and serum ganglioside antibody patterns in MS. Stevens A; Weller M; Wiethölter H Acta Neurol Scand; 1992 Nov; 86(5):485-9. PubMed ID: 1481629 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Matà S; Lolli F; Söderström M; Pinto F; Link H Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693 [TBL] [Abstract][Full Text] [Related]
4. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
11. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936 [TBL] [Abstract][Full Text] [Related]
12. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
13. Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma. Ene CD; Tampa M; Nicolae I; Mitran CI; Mitran MI; Matei C; Caruntu A; Caruntu C; Georgescu SR J Immunol Res; 2020; 2020():2491265. PubMed ID: 32855975 [TBL] [Abstract][Full Text] [Related]
14. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366 [TBL] [Abstract][Full Text] [Related]
15. Anti-GD2-like IgM autoreactivity in multiple sclerosis patients. Marconi S; Acler M; Lovato L; De Toni L; Tedeschi E; Anghileri E; Romito S; Cordioli C; Bonetti B Mult Scler; 2006 Jun; 12(3):302-8. PubMed ID: 16764343 [TBL] [Abstract][Full Text] [Related]
16. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. Stevens A; Weller M; Wiethölter H J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):361-4. PubMed ID: 7683329 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
18. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Eurelings M; Ang CW; Notermans NC; Van Doorn PA; Jacobs BC; Van den Berg LH Neurology; 2001 Nov; 57(10):1909-12. PubMed ID: 11723289 [TBL] [Abstract][Full Text] [Related]
19. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study. Lily O; Palace J; Vincent A Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514 [TBL] [Abstract][Full Text] [Related]
20. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Conrad K; Schneider H; Ziemssen T; Talaska T; Reinhold D; Humbel RL; Roggenbuck D Ann N Y Acad Sci; 2007 Aug; 1109():256-64. PubMed ID: 17785314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]